Epitomee medical is a public company developing and commercializing ingestible therapeutic devices, aimed to tackle some of today’s most prevalent chronic diseases with a self-managed, safer, kinder to the system and more manageable way.

Epitomee’s groundbreaking platform technology is based on self-expanding hydro-gel scaffolds folded into a standard pharmaceutical capsule, produced from biocompatible excipients, food additives, and food contact materials. Epitomee’s hydro-gel scaffolds can be engineered to be triggered by different zone-specific pH levels, allowing the allocation of an indication-specific deployment region for every product to enable an optimal therapeutic effect.